HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

V Craig Jordan Selected Research

Estrogens (Estrogen)

5/2022Estrogen for the Treatment and Prevention of Breast Cancer: A Tale of 2 Karnofsky Lectures.
1/2022Estrogen Receptor Complex to Trigger or Delay Estrogen-Induced Apoptosis in Long-Term Estrogen Deprived Breast Cancer.
1/2022PERK, Beyond an Unfolded Protein Response Sensor in Estrogen-Induced Apoptosis in Endocrine-Resistant Breast Cancer.
1/2022Estrogen Receptor and the Unfolded Protein Response: Double-Edged Swords in Therapy for Estrogen Receptor-Positive Breast Cancer.
1/2021Rapid Induction of the Unfolded Protein Response and Apoptosis by Estrogen Mimic TTC-352 for the Treatment of Endocrine-Resistant Breast Cancer.
10/2020Molecular Mechanism for Breast Cancer Incidence in the Women's Health Initiative.
10/2020Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer.
1/2020The Structure-Function Relationship of Angular Estrogens and Estrogen Receptor Alpha to Initiate Estrogen-Induced Apoptosis in Breast Cancer Cells.
10/2019Suppression of Nuclear Factor-κB by Glucocorticoid Receptor Blocks Estrogen-Induced Apoptosis in Estrogen-Deprived Breast Cancer Cells.
1/2019Estrogen-Induced Apoptosis in Breast Cancers Is Phenocopied by Blocking Dephosphorylation of Eukaryotic Initiation Factor 2 Alpha (eIF2α) Protein.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


V Craig Jordan Research Topics

Disease

161Breast Neoplasms (Breast Cancer)
05/2022 - 01/2002
83Neoplasms (Cancer)
05/2022 - 02/2002
28Osteoporosis
04/2017 - 01/2002
19Endometrial Neoplasms (Endometrial Cancer)
10/2020 - 02/2002
6Coronary Disease (Coronary Heart Disease)
10/2020 - 01/2002
6Neoplasm Metastasis (Metastasis)
06/2015 - 05/2003
5Postmenopausal Osteoporosis
05/2013 - 06/2009
4Prostatic Neoplasms (Prostate Cancer)
01/2016 - 02/2009
4Uterine Neoplasms (Uterine Cancer)
05/2013 - 01/2002
3Inflammation (Inflammations)
01/2019 - 09/2014
3Hot Flashes
10/2014 - 11/2007
3Carcinogenesis
10/2012 - 06/2006
2Male Breast Neoplasms (Male Breast Cancer)
01/2021 - 06/2014
2Stroke (Strokes)
10/2020 - 01/2007
2Leukemia
01/2018 - 01/2013
2Circulating Neoplastic Cells
06/2015 - 02/2009
2Carcinoma (Carcinomatosis)
01/2013 - 01/2007
2Hypersensitivity (Allergy)
06/2012 - 04/2006
2Hyperplasia
06/2010 - 05/2004
2Thrombosis (Thrombus)
09/2007 - 01/2007
2Cataract (Cataracts)
09/2007 - 06/2006

Drug/Important Bio-Agent (IBA)

84TamoxifenFDA LinkGeneric
05/2022 - 01/2002
83Estrogens (Estrogen)FDA Link
05/2022 - 01/2002
59Estrogen ReceptorsIBA
05/2022 - 01/2002
41Raloxifene Hydrochloride (Evista)FDA Link
11/2021 - 01/2002
33Selective Estrogen Receptor Modulators (SERM)IBA
11/2021 - 01/2002
28Aromatase InhibitorsIBA
01/2021 - 01/2002
27Estrogen Receptor alphaIBA
01/2020 - 03/2002
19Estrogen Receptor Modulators (Antiestrogen)IBA
05/2022 - 01/2002
19Pharmaceutical PreparationsIBA
11/2021 - 01/2002
19Hormones (Hormone)IBA
01/2019 - 01/2003
17Estradiol (Delestrogen)FDA LinkGeneric
11/2014 - 06/2002
14Proteins (Proteins, Gene)FDA Link
01/2019 - 12/2002
13LigandsIBA
01/2022 - 06/2002
9Fulvestrant (Faslodex)FDA Link
11/2007 - 11/2003
7SteroidsIBA
01/2018 - 08/2002
6Estradiol Congeners (Synthetic Estrogens)IBA
05/2022 - 04/2013
6Messenger RNA (mRNA)IBA
01/2014 - 12/2002
5Biological ProductsIBA
01/2022 - 04/2004
5Phosphotransferases (Kinase)IBA
01/2022 - 09/2005
54-hydroxy-N-desmethyltamoxifenIBA
10/2020 - 06/2014
5bazedoxifeneIBA
10/2014 - 01/2006
4Transcription Factors (Transcription Factor)IBA
01/2022 - 02/2003
4GlucocorticoidsIBA
10/2020 - 12/2014
4afimoxifene (hydroxytamoxifen)IBA
10/2020 - 03/2002
4Conjugated (USP) Estrogens (Premarin)FDA Link
01/2020 - 01/2013
4Therapeutic UsesIBA
12/2018 - 03/2011
4Progesterone Receptors (Progesterone Receptor)IBA
04/2017 - 12/2002
4Cytochrome P-450 CYP2D6 (CYP2D6)IBA
12/2014 - 11/2007
4LasofoxifeneIBA
05/2013 - 01/2006
4Biomarkers (Surrogate Marker)IBA
06/2010 - 06/2006
3Postcoital Contraceptives (Morning After Pill)IBA
05/2022 - 01/2011
3Progestins (Progestagens)IBA
10/2020 - 12/2014
3triphenylethyleneIBA
10/2020 - 01/2018
3Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric
12/2015 - 05/2005
3Phytoestrogens (Phytoestrogen)IBA
02/2015 - 10/2008
3Contraceptive Agents (Contraceptives)IBA
05/2013 - 01/2006
3Angiogenesis InhibitorsIBA
06/2010 - 12/2005
3Buthionine SulfoximineIBA
03/2009 - 01/2008
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2008 - 02/2005
3Growth Factor ReceptorsIBA
12/2007 - 01/2006
2EnzymesIBA
01/2022 - 11/2005
2EstetrolIBA
01/2021 - 10/2020
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 10/2012
2Progesterone CongenersIBA
10/2020 - 12/2015
2EstroneFDA Link
10/2020 - 10/2014
2Dexamethasone (Maxidex)FDA LinkGeneric
10/2019 - 09/2014
2NF-kappa B (NF-kB)IBA
12/2018 - 11/2003
2AndrogensIBA
01/2016 - 08/2010
2Androgen Antagonists (Antiandrogens)IBA
01/2016 - 11/2007
2ProlactinIBA
06/2014 - 01/2014
2LY 353381 (LY353381)IBA
05/2013 - 01/2006
2ChromatinIBA
06/2012 - 05/2003
2Androgen Receptors (Androgen Receptor)IBA
06/2012 - 02/2009
2Nucleosomes (Nucleosome)IBA
06/2012 - 05/2003
2Cyclin D1IBA
10/2011 - 04/2006
2P-2 (P 2)IBA
06/2010 - 06/2006
2Steroid Receptors (Steroid Receptor)IBA
09/2009 - 12/2006
2Drug CombinationsIBA
05/2009 - 04/2008
2Glutathione (Reduced Glutathione)IBA
03/2009 - 01/2009
2Paclitaxel (Taxol)FDA LinkGeneric
02/2009 - 05/2004
2Doxorubicin (Adriamycin)FDA LinkGeneric
02/2009 - 05/2004
2CaspasesIBA
05/2008 - 02/2005
2SurvivinIBA
05/2008 - 02/2005
2CholesterolIBA
09/2007 - 06/2003
2Cathepsin DIBA
02/2007 - 02/2006
2Insulin-Like Growth Factor I (IGF-1)IBA
02/2007 - 09/2005
2Glycogen Synthase (Synthase I)IBA
02/2007 - 04/2006
2ERRalpha Estrogen-Related ReceptorIBA
01/2007 - 01/2006
2ErbB Receptors (EGF Receptor)IBA
11/2006 - 04/2006
2Gefitinib (Iressa)FDA Link
11/2006 - 04/2006
2Trastuzumab (Herceptin)FDA Link
04/2006 - 09/2005

Therapy/Procedure

73Therapeutics
05/2022 - 01/2002
22Chemoprevention
07/2019 - 01/2002
7Drug Therapy (Chemotherapy)
07/2019 - 05/2003
4Hysterectomy
10/2014 - 05/2004
3Hormone Replacement Therapy (Therapy, Hormone Replacement)
10/2020 - 03/2011
2Precision Medicine
01/2017 - 02/2009
2Estrogen Replacement Therapy
02/2015 - 05/2011
2Transplantation
08/2010 - 02/2005